Lung Cancer
Conditions
Keywords
Clinician-Patient Communication, 16-001
Brief summary
The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.
Interventions
BEHAVIORALQuestionnaire
patients will fill out a questionnaire about their perceived stigma, satisfaction with communication, and psychological distress.
BEHAVIORALPatient Interview
Then they will participate in a brief in-person interview about their perceived stigma during the clinical consultation
BEHAVIORALAudio recordings of clinical consultations
BEHAVIORAL2-hour empathic communication skills training
2-hour empathic communication skills training
BEHAVIORALStandardized Patient Assessments
pre-training SPA, post-training SPA
BEHAVIORALTraining evaluation
Clinicians will complete an evaluation assessing the empathic communication training module.
BEHAVIORALPatient recruitment
6 of the clinician's patients (3 pre-training, 3 post-training) will be recruited to complete brief surveys assessing clinician communication
Sponsors
Memorial Sloan Kettering Cancer Center
Hamad Medical Corporation
University of Arizona
Weill Medical College of Cornell University
University of Florida
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Patients with confirmed lung cancer diagnosis or mass suspicious of lung cancer as per clinician report and/or EMR * Lung cancer diagnosis or suspicious mass as per clinician report/EMR within 0-6 months of consent or within no more than three visits to participating clinician * Participating clinician approves his/her patient's participation in this study per clinician report. * Former (at least 100 cigarettes in lifetime and quit more than 30 days prior to enrollment) or current smoker (lifetime smoker who reports cigarette smoking within the past 30 days) as per self report or EMR; * English fluency (determined through EMR or clinician report), as we do not have the resources to translate the consultations from other languages or the surveys to other languages; * Patients must be 18 years old or older Clinician Inclusion Criteria: * An MSK attending physician (radiologists, medical oncologists, and surgeons), Nurse Practitioner (NP), Physician Assistant (PA), Fellow, Resident or Clinical Nurse Specialist (CNS) or Clinical Nurse (RN) who is a member of the Thoracic Disease Management Team or Pulmonary Service currently treating thoracic patients at MSK as per self report * Clinical has individual clinic consultations to discuss adult health assessment and/or smoking history with the target patient population: English-speaking, at least 18 years of age, has a suspicious lung mass or confirmed diagnosis, is a former/current smoker, has had no more than 3 visits with clinician or had diagnosis in past 6 months as per self-report.
Exclusion criteria
Clinician
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Part 1: Systematic coding of clinical encounters and the perceived stigma within the clinical consultation | 1 year | interview along with patient-reported data from the post-consultation questionnaire will be used. |
| Part 1: All variables (stigma, satisfaction with communication, psychological distress) | 1 year | will be measured via post-consultation questionnaires |
| Part 2: We will pilot test the effectiveness of the empathic communication skills training module | 1 year | for clinicians: physicians, nurse practitioners, physician assistants, fellows, residents, clinical nurses, and clinical nurse specialists by using the communication skills training module |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| # of patients referred to MSK's Tobacco Treatment Program (TTP) | 1 year | will be determined via review of the medical record and/or Tobacco Treatment Program database |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORJamie Ostroff, PhD
Memorial Sloan Kettering Cancer Center
Outcome results
None listed